1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZFP36L2 CTRPv2 pan-cancer AAC 0.28 3e-14
mRNA IRF2BP2 CTRPv2 pan-cancer AAC 0.25 7e-12
mRNA LYST CTRPv2 pan-cancer AAC 0.24 1e-10
mRNA SH3TC2 CTRPv2 pan-cancer AAC 0.25 5e-10
mRNA SPRY2 CTRPv2 pan-cancer AAC 0.23 5e-10
mRNA SPRY4 CTRPv2 pan-cancer AAC 0.23 1e-09
mRNA TNFRSF1B CTRPv2 pan-cancer AAC 0.21 6e-09
mRNA ACY1 CTRPv2 pan-cancer AAC 0.22 8e-09
mRNA CEBPA CTRPv2 pan-cancer AAC 0.2 9e-09
mRNA GPR35 CTRPv2 pan-cancer AAC 0.22 1e-08
Download CSV